NCT04908176 2024-12-13A Drug-drug Interaction Study of Avapritinib and MidazolamBlueprint Medicines CorporationPhase 1 Completed10 enrolled
NCT02561988 2023-03-17(EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid MalignanciesBlueprint Medicines CorporationPhase 1 Completed86 enrolled 1 FDA
NCT02508532 2022-06-21(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid TumorsBlueprint Medicines CorporationPhase 1 Completed250 enrolled 36 charts 2 FDA